Desipramine modulation of sigma and opioid peptide receptor expression in glial cells
- PMID: 1664948
- DOI: 10.1016/0196-9781(91)90144-e
Desipramine modulation of sigma and opioid peptide receptor expression in glial cells
Abstract
Exposure of C6 glial cell cultures to desipramine induced the appearance of opioid receptors and up-regulated sigma receptors. Opioid binding was demonstrated with 3H-etorphine and 3H-dihydromorphine (DHM), but was not observed with the mu, delta and kappa ligands 3H-DAMGE, 3H-DADLE or 3H-(-)ethylketocyclazocine in the presence of specific blockers, respectively. Competition experiments with 3H-DHM and either (-)naloxone or (+)naloxone indicated the presence of authentic opioid receptors. In similar studies with beta-endorphin, its truncated form (1-27) or their N-acetyl derivatives, beta-endorphin proved to have the highest affinity. Opioid receptors in glial cell aggregates were primarily kappa, with few mu and delta sites. Desipramine increased Bmax values for kappa but not mu and delta.
Similar articles
-
Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.Mol Pharmacol. 1983 Jul;24(1):23-9. Mol Pharmacol. 1983. PMID: 6306437
-
Modulation of rat brain opioid receptors by cannabinoids.J Pharmacol Exp Ther. 1987 May;241(2):534-9. J Pharmacol Exp Ther. 1987. PMID: 3033219
-
Distinct subtypes of the opioid receptor with allosteric interactions in brain membranes.J Neurochem. 1986 Apr;46(4):1118-28. doi: 10.1111/j.1471-4159.1986.tb00626.x. J Neurochem. 1986. PMID: 3005504
-
Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.Mol Pharmacol. 1986 Aug;30(2):81-9. Mol Pharmacol. 1986. PMID: 3016503
-
Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study.Neurosci Lett. 1985 Apr 19;55(3):317-23. doi: 10.1016/0304-3940(85)90455-0. Neurosci Lett. 1985. PMID: 2989733
Cited by
-
Evidence for the implication of phosphoinositol signal transduction in mu-opioid inhibition of DNA synthesis.J Neurochem. 1992 Sep;59(3):1145-52. doi: 10.1111/j.1471-4159.1992.tb08357.x. J Neurochem. 1992. PMID: 1322969 Free PMC article.
-
Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes.ACS Chem Neurosci. 2014 Feb 19;5(2):106-14. doi: 10.1021/cn400172n. Epub 2013 Dec 5. ACS Chem Neurosci. 2014. PMID: 24304333 Free PMC article.
-
Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells.J Neurochem. 1998 May;70(5):1819-25. doi: 10.1046/j.1471-4159.1998.70051819.x. J Neurochem. 1998. PMID: 9572265 Free PMC article.
-
Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cells.J Neurosci. 1994 Oct;14(10):5858-64. doi: 10.1523/JNEUROSCI.14-10-05858.1994. J Neurosci. 1994. PMID: 7931548 Free PMC article.
-
Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.Pharmacol Res. 2016 Dec;114:75-89. doi: 10.1016/j.phrs.2016.10.007. Epub 2016 Oct 20. Pharmacol Res. 2016. PMID: 27773824 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials